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An investigation into the genetic differences in the humoral
immune response of swine following vaccination with a sheep red blood
cell solution (SRBC) and a commercially prepared Pasteurella multocida 
(serotype PO bacterin (PmA) was conducted on a total of 268 pigs flun
two individual trials. This study was also conducted to evaluate the
humoral immune response of pigs to a non-pathogen (SPEC) and a known
pathogen to swine (P). The pigs used in the first trial were fL(mt22
litters born between January 1991 and July 1991. The pigs consisted of
Hampshire x Yorkshire (n=114), purebred Yorkshire (n=70) and Hampshire
(n=17). Individual pigs were vaccinated at five and eight weeks of age
with 2 ml of a 5% SRBC solution and 1 ml of a killed PmA bacterin. AL
11 weeks of age 8 uE of blood was collected frun each animal and serum
prepared to determine antibody titer levels against the two antigens by
agglutination methods. Pigs utilized in the second study consisted of
purebred Duroc (n=11), Haupshire (n= 10), Landrace (n=12) and Yorkshire
(n=11) and crossbred Hampshire X Durcc (n= 12) and Yorkshire X Landxace
(n=12). Results of trial 1 indicate that breed of pig affected the
immune response against both PmA (P<.01) and SRBC (P<.01), with the
Hampshire x Yorkshire crossbred pigs having higher titer levels against
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the PmA than either Hampshire or Yorkshire purebred pigs. The purebred
Hampshire were not statistically different fram eitlIr the purebred
Yorkshire or the Hampshire x Yorkshire LrusSbred pigs in their antibody
response to SRBC; however, the Hampshire x Yorkshire c/u6Sbred pigs were
statistically higher than the Yorkshire pigs. Results from trial 2
indicate highly significant (P<.01) breed differences in the humoral
immune response to PmA. Purebred Landrace pigs were superior to both
Duroc and Hampshire purebred pigs in their immune response to PmA.
Purebred Yorkshire and crossbred Yorkshire X Landrace pigs were superior
to purebred Durtcs in their immune response to PmA. NO other
significant differences among breeds of pigs occurred in trial 2.
A low positive coirelation of .22 was found between the pigs'
antibody responses to PmA and SRBC in trial 1. Correlation differences
among breeds were found between average daily gain while an test and the
humoral immune response to both PmA and SRBC. Roaults suggest that
further studies into breed differences of the immune response in swine
are warranted. Results also suggest that further studies are needed to
evaluate sheep /Ed blood cells as a suitable antigen When conducting




Infectious diseases cost livestock producers millions of
dollars each year. These costs include mortality, condemnation of
products, veterinary services and antibiotic costs. Disease also costs
producers in more hidden ways: increased days to market, poorer feed
efficiency, decreased milk and/or egg production. The It t hidden cost
in seedstock herds may be a reduction in genetic progress resulting in
an increase in phenotypic variance due to disease (Gavora and Spencer,
1983). It is estimated that disease costs U.S. swine producers in
excess of 1.5 billion dollars annually (Rothschild, 1985). Swine
producers have generally focused an vaccination, sanitation, medication,
and eradication to produce healthy hogs. The identification and
selection of pigs with superior immune systems has largely been ignored
as a means to produce healthder swine.
There are various shortcomings of current methods to control the
inL:dence of disease Immunity Obtained by the administration of a
vaccine varies widely (Rothschild, 1985). Disinfectants used in
sanitizing swine facilities also vary in the organisms controlled
(Jensen and Kaeherle, 1975). In recent years more controls have been
placed an the use of antibiotics in livestock prnduction; therefore the
cost of using antibiotics may became prohibitive. Eradication is both
an expensive and impractical method of controlling a large number of
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diseases in a swine herd. Other vectors of diseases that are infectious
to swine also make eradication difficult. The use of identification and
selection for improved immune response used in conjunction with more
conventional methods of controlling disease might prove productive.
There has been limited research exploring the identification of
animals with superior immune systems and the results of these limited
studies vary with the species utilized. The level of disease resistance
present in livestock herds is primarily due to natural selection and a
correlated response with production traits (Gavora and Spencer, 1983).
Research indicates there is a genetic component of the immune response
which may be influenced by the environment (Warner et al., 1987).
Correlated responses between production traits and immune response vary
and will influence whether animal breeders will be successful in
simultaneous improvement of both groups of traits.
The purpose of this study was two fold: to explore the differences
in the immune response among breeds of swine, and to determine if the
pigs' immune systems respond similarly to sheep red blood cells (a non-




Thoughts that the immune response, against a variety of antigens,
may be under same genetic control are not new. As early as 1968
researchers had discovered that poultry resistant to Wrek's disease was
related to B alloalleles of the major histocampatibility complex (Cole,
1968). The major histocampatibility complex is intimately involved in
the immune response of animals to foreign antigens (Biozzi et al.,
1979). A study conducted with sheep also indicated the genetic
influence on the quantitative immune response of sheep to chicken red
blood cells (CRBC) (Nguyen, 1984).
In cattle, genetic controls are less defined. The major
histocampatibility complex of cattle is known as the Bovine Leukocyte
Antigen (BoLA). The exact control exerted by the BoLA over the immune
response in cattle is not well understood (Lewin, 1989). It is known
that BoLA differences do exist and that BoLA heterozygotes were
significantly better than hamozygotes in their immune response to a
synthetic peptide antigen (Lewin, 1989).
The swine major histocampatibility complex is known as the swine
Leukocyte Antigen (SLA). It is known that the SLA is related to
production traits such as litter size, birth weight, weaning weight and
piglet mortality (Ho9janson et al., 1989). However, little is known
concerning the effects of the SLA an disease resistance.
3
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Efforts in determining immune response iifferences between lines or
breeds of livestock have focused on exposing an animal to an antigen(s)
and measuring differences. Current levels of disease resistance have
likely resulted floulnatural selection gained when selecting farm
animals for production traits only. Direct selection for disease
resistance has largely been ignored (Gavora and Spencer, 1983).
Disease resistant lines within breeds have been developed in
pcultry. Two lines of White Leghorn thickens (High Avian, HA) and (Low
Avian, LA) differed in their susceptibility to Mycoplasma gallisepticum, 
Escherichia coli, Staphylococcus aursus, New Ctle disease and Merek's
disease (Gross et al., 1980). TWo chick lines were divergently selected
fourteen generations for antibody response to sheep red blood cells
(SRBC); high and low antibody response lines were produced and
maintained (Martin et al., 1988).
Breed differences have also been explored in cattle. NO
differences in the humoral immune response were found among Angus,
Hereford and Red Poll calves vaccinated with Infectious Bovine
Rhinotracheitis Virus (IBRV) (Muggli et al., 1987).
HUmoral immune response differences in swine have been found by a
nuMber of researchers. Differences between breeds have varied with the
antigen utilized to stimulate the immune system. Buschmann et al.
(1974) demonstrated significant breed differences when Sheep red blood
cells (SRBC) were utilized as the antigen. Purebreeds utilized were
Duroc, Hampshire, Chester White, Large White, Pietrain, German Landrace
and German FrielsChwein. Crossbred pigs which were German Landrace X
Hampshire and Hampshire X Pietrain were also utilized in this study.
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Breed differences in the number of plaque fanning cells (PFC) were
measured (an indication of the magnitude of immune response). It was
found that Duroc and Chester White had the highest yield of (PFC) while
Pietrain had the lot (Ruschrrann et al., 1974)_ Buschmann et al.
(1974) concluded that differences in the immune response to SRBC among
breeds should be interpreted as genetic variation.
TWo studies conducted by Rothschild et al. (1984a and 1984b) found
breed differences among pigs' humoral immune response. The first study
utilized Bordetella bronchiseptica as the antigen. Chester White pigs
had higher post-vaccination titers than any of the other breeds tested.
Yorkshire and Landrace ranked intermediate in their response and were
different (P <.01) flow Hampshire and Duroc pigs (Rothschild et al.,
1984a). The second study conducted by Rothschild et al. (1984) utilized
a modified live Pseudorabies virus as the antigen. It was found that
the Yorkshire and Chester White pigs had higher average titers (P <.01)
than Durcc and Landrace pigs (Rothschild et al., 1984b). Rothschild
(1984b) concluded that breed differences may effect the efficacy of
vaccines among breeds.
Crossbreeding to improve immune response or disease resistance has
not been researched extensively. A study conducted by Collor (1989)
demonstrated that Fl Hybrid mice resulting fram crossing two highly
inbred strains of mice, BALB/c and C57BL, exhibited a highly significant
increase in the humoral immune response to SRBC over their
contemporaries of parental strain breeds. A 177.1% degree of heterosis
was found in the humoral immune response to SRBC in the Fl hybrid when
compared to the contemporary inbred strains (Gailor, 1989).
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Kennedy and Mbxley (1980) concluded that pure breeds did not differ
in their susceptibility to atrophic rhinitis; however, rhinitis
incidence was lower and snout scores were improved 10% amcng two-breed
c/ ses when compared to contemporary purebreeds (Kennedy and Vbxley,
1980). It was concluded that the differences represent an estimate of
hetet is under the assumption that the pure breeds did not differ in
their susceptibility to atrophic rhinitis.
The study, previously mentioned, conducted by Busthmann (1974)
revealed that the Fl clusabred Pietrain X Hampshire were superior to
purebred Pietrain pigs in their immune response to SRBC. A positive
deviation of 11.8 percent in the number of PFC was found for the
Pietrain X Hampshire when compared to purebred Pietrain.
In order to capitalize on humoral immune response differences it
must be de,-ermined if an improvement in the humoral immune response can
be Obtained by selection. Eide and co-workers (1991) selected Norwegian
dairy goats for high and low antibody response to diphtheria toxoid for
12 years or approximately 5.5 generations. an phenotypic values from
each line diverged slightly until the fourth yr. After the fourth
year no further divergence occurred. Rpalized heritability estimates
were approximately .19 in the first selection trial, tut approached zero
in later cycles.
Selection in other species has also been successful. Ntirtin et al.
(1989) dernanstrated that selection in poultry was successful in
improving the immune response to SREC. Warner et al. (1987) state that
successful immune response selection trials have been conducted in
sheep, guinea pigs and mice. Table 1, adapted fram Gavora and Spenser
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(1983) and Rothschild (1985) illustrates several approaches to breeding
and selecting for genetic resistance to disease. The rrethcds outlined
indicate that selection can be utilized in a nuMber of ways to improve
the immune response of livestock. Unfortunately, a good response to one
antigen does not necessarily predict a good response to another antigen
(Warner et al., 1987). Thus selection for geneloal disease resistance by
the response to a single antigen may prove to be difficult.
Heritability estimates for the immune response in swine have
varied. Warner et al. (1987) reported a study conducted by Li in which
a heritability estimate of .62 was Obtained for the irmtine response to
Bordetella bronchiseptica in Chester White swine after one generation.
Is.leker et al. (1987) Obtained a heritability estimate in swine of .18 +
.09 for Pseudorabies titers at 56 days of age and .52 + .15 at 119 days.
Rothschild et al. (1984) found a heritability estimate of .10 + .12 to
Bordetella branchiseptica. Rothschild (1985) reported that European
studies estimate the heritability of resistance to atrophic thinitis to
he from .12 to .42 in swine. The heritability of the immune response to
IBRV vaccination ranged from -.06 + .08 to .21 + .12 in beef calves
(Maggli et al., 1987). Nguyen et al. (1984) reported a heritability
estimate of .82+ .32 for the immune response to thicken red blood cells
(BC) in sheep. The heritabilities estimated further support the idea
that selection for immune responsiveness is possible, but successful
selection varies greatly depending on the antigens or the infectious
agent involved.
Ideally, the immune response would be well associated with various
production traits making it conducive to simultaneous progress when
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selecting for a single trait. Researchers have found this not always to
be the case. Mbeker et al. (1987) found an antagonistic relationship
between the immune response to a mcdified live pseudorabies vaccine and
the production traits of 21-day weight, 42-day weaning weight and
average daily gain in swine. Pigs resistant to the K88 strain of
Escherichia coli grow slower than their susceptible litterHutes
(Gibbons et al., 1987). Shook (1989) states that high producing dairy
cows are more susceptible to mastitis resulting in the high producing
cow having a Shorter longevity than its low prrilucing herdnutes.
Identification and selection of animals with superior immune
system, and the application to commercial swine production still remains
a formidable prbblem. Suitable antigens, well associated with
production traits, used to access the immune response remain elusive.
Crossbreeding of pure lines or breeds appears to improve the immune
response in various species of livestock. Breed differences in the
humoral immune response in pigs exist; results vary depending on the
antigen involved in the stimulation of the immune system.
0-1APrER 3
MA'I'ERIALS AND MEITICES
Animals. TWo trials were conducted to evaluate swine breed
differences in the humoral immune response to sheep red blood cells
and/or Pasteurella multocida (serotype P). The first trial was conducted
at the Western Kentucky University farm. TWenty-two litters farrowed
between January 1991 and July 1991 provided the pigs utilized in this
trial. The pigs used in the study consisted of crosabred Hampshire x
Yorkshire (n=114) and purebred Yorkshire (n=70) and Hampshire (n=17).
All dams were primiparous with the exception of the last six litters
farrowed which were from second litter sows. All sires and dams were
dotained from specific pathogen free (SPF) purebred herds. Pigs were
weaned at five weeks of age and given a minimum of three days adjustment
period before beginning the trial. All pigs were fed a standard
commercial 18% crude protein ration medicated with Furazolidone,
Oxytetracycline and Arsanilic Acid at the rate of 200, 100, and 90 grams
per tan, respectively. Pigs were housed in a nursery at 26
0
 to 30°
Celsius (C). Pigs were randomly assigned to 1.22 m x 1.22 In wire floor
decks with approximately ten pigs per pen for the first three weeks of
the trial. Pigs were then moved to 1.52 In x 3.65 m totally slotted
f1 i pens f_ Juiation of the trial. Pigs were fed ad-libitum and
had access to fresh water at all times.
9
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The second trial was conducted utilizing pigs from a commercial
seedstotk herd. Pigs used in this trial /epl ented forty-four litters
farrowed in June and July of 1991. The large nuMber of litters
Lepreserted was an attempt to sample pigs from a large number of sires.
The pigs utilized to conduct the trial consisted of purebred Yorkshire
(n=11), Landrace (n=12), Duroc (n=11) and Hampshire (n=10) females, and
crossbred Hampshire X Duroc (n=12) and Yorkshire X Landrace (n=12)
females. Pigs were housed in grow-finish total confinement buildings. A
temperature of 21° to 26° C was maintained within the grow-finish
buildings. Pigs were randomly assigned to 3.65 m x 4.87 m or 3.65 m x
3.05 m (a stocking density of .414 to .506 square meters per pig was
used) totally slotted floor pens for the full six week trial. Pigs
were provided ad-libitum access to a standard 16% crude protein meal
ration medicated with BMD (Bacitracin Methylene Disalicylate 309 per
ton) or ASP 250 (Aureamycin 100g per tan, Sulfamethazine 100g per ton
and Penicillin 50g per ton). Pigs were provided access to fresh water
at all times.
The number of sires /presented within each breed of experimental
pigs from trials 1 and 2 is noted in table 2.
Antigens and Immunizations. Sheep Red Blood Cells (SRBC) and
Pasteurella multocida serotype A (PmA) were the antigens selected for
use in this study. Sheep red blood cells were selected because they are
non-pathogenic to swine and would not be noniilly found in the pigs'
environment. Sheep red blood cells were also commercially available in
a standard suspension (Cleveland Scientific, Bath, Ohio). A killed
Pasteurella multocida serotype A bacterin was selected because it is a
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known pathogen to swine and standardized procedures for measuring serum
antihodies were commercially available (Ambico, Inc., Pallas Center,
Iowa).
Sheep red blood cells were refrigerated in Alsever's solution at
7° C until use. The SPECS were washed two times in physiological saline
prior to diluting to the dPqired concentration. A 5% SRBC solution was
determined sufficient to elicit a measurable immune response when
injected intramuscularly (IM) in pigs (Seymour, 1985). The SRBC antigen
was made by mixing 5 ma of SPECS with 95 ml of physiological qaline
resulting in the 5% SPEC concentration. The Pasteurella multocida 
serotype A bacterin was Obtained prediluted to a known concentration of
1 x 10
10 
colony forming units (cfu) per ml. The diluent used was a 12%
rehydrogel adjuvant (Alnico, Inc., PR1las Center, Iowa0.
Pigs utilized in the first study were weighed at approximately
five weeks of age and given the initial antigen injections to stimulate
the primary immune response. It was determined that five week old pigs
were of sufficient age to mount an immune response to an antigen(s)
(Haye and Kornegay, 1979). Throe weeks following primary injections, a
second injection of each antigen was given in order to stimulate the
secondary immune response. Pigs were immunized intramuscularlly (EM)
utilizing separate neck injection sites for each antigen. Antigen
injections consisted of 2 mil of the 5% SPEC and 1 ml of the AmA
solution. Pigs were weighed at the time of final blood collection to
determine average daily gain.
Pigs used in the second study were given an initial 1 ma injection
of Pasteurella multocida (serotype A) at an average of twelve weeks of
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age. The antigen was injected Mil into the neck. A second 1 ml
injection of the PmA antigen war given three weeks following the initial
injection to stimulate the secondary immune response.
Blood Collection. A blood sample was taken from an initial group
of 45 pigs at weaning to determine baseline antibody levels for the two
antigens involved in trial 1. Ten random blood samples were taken from
pigs in trial 2 to determine if any antibodies to PmA existed prior to
the initiation of the trial. Blood samples were collected three weeks
after the initial antigen injections to determine the primary immune
response and again three weeks later to determine the secondary immune
response. Previous research indicated that immunoglobulin G (IgG) does
not appear in the sera of pigs for seven to fourteen days following the
initial injection of antigens (Roth, 1992). Blood was collected via the
anterior vena cava with a 16 gauge, 38.1 rrm needle attached to a
disposable 10 rra syringe. Each sample was placed in a Serum Separation
TUbe (SST) (Beckton Dickinson and Company, Rutherford, New Jersey) and
allowed to clot at aMbient temperature. Sera were harvested by
centrifuging each blood sample for ten minutes at 1100 g. The sera were
harvested and each sample was divided into two 10 rrm x 75 run
borosilicate culture tubes. The serum samples were then frozen at
approximately -10° C until laboratory analyses were conducted.
Serum Assays. The serum samples were taken to the B eathitt
Veterinary Center Serology Laboratory, in Hopkinsville, KY, to determine
antibody levels by microtitration. Serum samples were thawed in a 37° C
water bath for thirty minutes. Antibody levels against PmA were
determined by a direct Pasteurella agglutination assay (Antic°, Inc.,
13
Pallas Center, Iowa). Standard positive and negative as well as all the
test sera were pre-diluted 1/10 in PAST diluent composed of 5% sodium
chloride, 1/1000 rtil ton:I:din, 0.05% bovine serum albornn and distilled
water. TWenty-five microliters (u1) of diluent was added to wells in
columns B through L of each microtiter plate. Each sample was assayed
in duplicate by placing 25p1 of the test sera in columns A and B in two
rows of the microtiter plate. The samples were serially diluted from
columns B through L. Bulk PmA antigen was diluted 1 to 400 in PAST
diluent and 25)ul of diluted antigen was added to each well to give a
final dilution scheme of 1:20 to 1:58,240. The plates were
mechanically shaken for approximately one minute before being incubated
at 37° C for two hours and refrigerated at approximately 4° C overnight.
Antibody titer was recorded as the reciprocal of the highest dilution at
which a visible agglutination occurred. The results were considered
valid if the duplicated samples' agglutination end-points were within
one well or one dilution of each other. Antibodies to SR BC fram each
sample were determined by a hemagglutination assay in 8 x 12 well U-
bottam microtiter plate (DynaTech Laboratory Products, Alexandria,
Virginia). Serum samples were placed in a 56° C water bath for thirty
minutes to inactivate the complement prior to assaying for SRBC
antibodies. Twenty-five)ul of serum was serially diluted in duplicate
with 25)ul of physiological saline to give a final dilution scheme of
1:2 to 4,096. TWenty-five)ul of a 2% SR BC suspension was added to each
well and plates were mechanically shaken for approximately one minute.
The plates were incubated at approximately 25° C for thirty minutes and
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then refrigerated for approximately two hours. Antibody titer was
recorded as the Lciprocal of the highest dilution at which visible
agglutination had occurred. If the end-points of duplicated assays were
not within one dilution of each other, the results were considered
invalid.
Statistical Analysis. The reciprocal of the highest dilution
at which a visible agglutination occurred was transformed using log2
(because the assay utilized a serial doubling dilution scheme) to
nori1ize the distribution. The General Linear Mbdels procedure (GINI)
of the Statistical Analysis Services (SAS), (SAS, 1989), was used to
analyze these data. Data frkintrials 1 and 2 were analyzed separately.
An analysis of variance Ammv was performed on these data to analyze
for significant differences, and Duncan's Mbltiple Range 040 test was
used to separate breed mean differences. The statistical model used to
analyze these data is shown in figure 1. ANOVA tables are shown in
tables 3 through 6.
CHAPTER 4
RESULTS AND DISCUSSION
None of the 45 serum samples from trial 1 that were collected
prior to immunization contained detectable levels of antibodies to SRBC
or PmA. The ten serum samples collected prior to the start of trial 2
had a preexisting titer range of negative at the 1:20 dilution to
positive at the 1:80 dilution. The distributian of Pm? and SRBC
agglutination titers fallowing immunizations is shown in figures 2 and 3
for trial 1 and figure 4 for trial 2. The titer values were transformed
into log2, and utilizing the Shapiro-Wilk test, it was determined
(Pc.0001) that the values were naatully distributed in both trials.
Breed average of pigs' secondary humoral immune response to SRBC and PmA
is illustrated in table 7. Results from trial 1 indicate that breed
affected the humoral immune response against PmA (1/4.0001) and SRBC
(1/4.0029) with the Hampshire x Yorkshire crossbred pigs having higher
PmA titer levels than either Hampshire or Yorkshire purebred pigs. The
two pure breeds were not statistically different in their humorsl immune
response against FA. The purebred Hampshire pigs were not
statistically different from either the Hampshire x Yorkshire crossbred
pigs or the Yorkshire purebred pigs in their humorsl immune response
against SRBC; however, the Hampshire x Yorkshire crossbred pigs were
statistically higher than the rxa'ebrul Yorkshire (1/4.0029).
15
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Highly significant breed differences (P<.0001) for average daily
gain were noted from trial 1. Breed average daily gain while on test is
illustrated in table 7. The Hampshire X Yorkshire pigs had higher
average daily weight gain during the test period than either Hampshire
or Yorkshire purebred pigs. The purebred Yorkshire pigs also had higher
average daily weight gain wfidle on test than purebred Hampshire pigs.
Pigs utilized in trial 2 were given injections of Pasteurella 
nultocida (serotype PO only. Breed average for pigs' humoral immune
response to PmA is shown in table 8. Results indicate highly
significant breed differences. Landrace pigs were statistical  ly higher
in their humoral immune response to PA than either Duroc or Hampshire
breeds of pigs. Yorkshire purebred and Yorkshire X Landrace crossbred
pigs were higher than Duroc pigs in their humoral immune response to
PmA. NO other significant differences were abserved in trial 2.
Trial 1 also revealed a low positive coefficient of corlelation of
.22 between the secondary immune responses to SRBC and PmA.
Coefficients of collelation by breed and for the overall study are found
in table 9. Substantial numerical differences in the co/relations
between the secondary immune response to both antigens and average daily
gain were also found.
The results of this study suggest that differences do occur in the
hunoral immune response of pigs among breeds. This study also suggests
that crossbred pigs may have superior immune systems to combat known
pathogens to swine than their purebred counterparts.
The results of the two trials using PmA as the antigen, closely
reseMble the results of Rothschild et al. (1984a) where purebred
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Yorkshire and Landrace pigs were superior to purebred Duroc and
Hampshire pigs in their humoral immune response to Bordetella
bronchiseptica. However, when Rothschild et al. (1984b) utilized a
modified live Pseudorabies vaccine as the antigen the results differed.
In that study purebred Yorkshire, Chester White and Hampshire pigs were
statistically higher in their humoral immune response than purebred
Landrace pigs, while purebred Durocs were intermediate in their
response. These results conflict with the current demcnstration where
purebred Landrace pigs had the highest transformed titer average of any
pure breed used in the trial. The different results support the idea of
breed differences that are dependent on the antigen used to conduct the
experiment.
The results from trial 1 utilizing sheep red blood cells (SRBC) as
the antigen differ fram those results obtained by Buschmann et al.
(1974) who also used SRBC as the antigen. Buschmann et al. (1974) found
that purebred Large White (considered similar to Yorkshire pigs in the
United States) were superior to purebred Hampshire in the average number
of plaque-forming cells (an indication of the intensity of immune
response). The current study demonstrated that the purebred Hampshires
were superior to purebred Yorkshire when measured by a hemagglutination
method, but the limited number of purebred Hampshires utilized in the
current study may not have given a true estimate of breed differences.
The superior humoral immune performance of crossbred pigs in this
study also concurs with studies conducted by nailor (1985), Ruschmann et
al. (1974), and Kennedy and Moxley (1980). Romarch using two highly
_inbred strains of mice were used to create Fl offspring. It was found
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that the F1 mice had 10.1% higher titer values to SRBC than the parent
strains of mice (Gallor, 1985). An experiment conducted by Buschmann et
al. (1974) found that Pietrain X Hampshire pigs were 11.8% superior in
their immune response to SRBC than contemporary purebred Piet rain. A
study conducted by Kennedy and Maley (1980) found that cruosbred
Yorkshire X Landrace, Yorkshire X Lacombe and Landrace X LacoMbe pigs
had 1.1% less rhinitis incidence and 10.1% better thinitis snout scores
than contemporary purebred Yorkshire, Landrace and Lacambe pigs. The
results of all the trials to date suggest an advantage for the crossbred
pig in building immunity to a variety of antigens.
The current study indicates than PmA could be a suitable antigen to
detect differences in the humoral immune response among breeds and
Individual pigs should selection for immune response became
advantageous. The results also support the conclusion of Warner et al.
(1985) who stated that selection for a superior immune response to one
antigen does not guarantee a superior immune response to all antigens.
The results from this study indicate the coefficients of correlation
between average daily gain and the humoral immune response to the
antigens PmA and SRBC to be extrenely variable as noted in table 8. The
correlations suggest that selection only for disease resistance wculd
yield very little or negative progress on average daily gain, an
economically important trait in swine. Meeker et al. (1987) and Gibbons
et al. (1977) found similar relationships between economically
important traits and the immune response and/or disease resistance.
No previous articles reviewed utilized SRBC and an antigen known to
be pathogenic in the same study. Variable correlations, noted in table
19
8, between the humoral immune response to SRBC and AmA raise questions
concerning the suitability of SRBC as an antigen to evaluate the pigs'
humoral immune response capabilities to known pathogens of swine.
alors in the accessment of the pigs' immune response are likely if the
immune response to SRBC does not consistently and closely mimic the
iratme response to known pathogens of swine.
CHAPTER 5
IMPLIaxrioNs
This study suggests that breed differences exist in the immune
response to PmA, a known pathogen to swine. This effort also suggests
that crossbreeding improves the immune response to PmA. Canmercial
swine producers could exploit breed differences in a crossbreeding
program to improve the immune response in pigs. A poor overall
correlation was found between the immune response to PmA and AEC,
indicating that simultaneous improvement in production traits and the
immune response may be difficult. Comparing previous studies to the
current, it appears that different results can be Obtained when various
antigens are utilized in the assessment of the immune response among
pigs. Therefore, further work may be warranted to identify suitable
antigens that could be used in identifying a general improverrent in the
immune response among pigs. Results also suggest that non-pathogenic
organisms such as SR3C8 are poor indicators of the pigs' humatal immune
response to known pathogens such as M. Above all, this study
indicates boundless research opportunities that could be conducted to
learn more about the relationship between the immune system and
economically important traits in swine.
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Table 1: Approaches to breeding for genetic iistance to
disease a.
Type of Method Effects on Expression Cbsts
Selection production of Disease
of Breeders Resistance
DiL  t 1. Observe
Breeding 0 Questionable 0
Stock
2. Challenge
Breeding Negative Good Low -
Stock High
3. Challenge




Challenge 0 Good Low
2. Genetic
Markers 0 Good Low
Mblecular 1. Construct
Genetics Resistant 0 Good High
Genotypes
a Portions adapted from Gavora and Spenser, 1983 and
Rothschild, 1985.
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Table 2. NUMber of sires /epresented within each breed of
experimental pigs fram trials 1 and 2.
Breed of nuMber of sires





Hampshire X 2 0
Yorkshire
Hampshire X 0 4 Hampshires
Duroc and 2 Durccs
Landrace X 0 3 Yorkshires
Yorkshire and 1 Landrace
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Table 3. Analysis of variance for pigs' secondary
response to Sheep it.1 blood cells from
humoral immune
trial 1.
Source Degrees of Sums of an F - PrObability
Freedom Squares Squares Value > F Value
Total 198 827.08
Breed 2 48.01 24.00 6.04 .0029
Error 196 779.07 3.97
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Table 4. Analysis of variance for pigs' secondary




Source Degrees of Sums of an F - PrObability
Freedom Squares Squares Value > F Value
Total 198 348.15
Breed 2 42.42 21.21 13.6 .0001
196 305.73 1.56EILur
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Table 5. Analysis of variance for pigs' average weight gain
while an test from trial 1.
Source Degrees of Sums of Mean F - Prabability
Freedom Squares Squares Value > F Value
Total 198 2.61
Breed 2 .68 .34 34.52 .0001
196 1.93 .009Error
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Table 6. Analysis of variance for pigs' secondary




Source Sums of an F - PrdbabilityDegrees of
Freedom Squares Squares Value > F Value
Total 67 89.22
Breed 5 19.45 3.89 3.46 .008
62 69.77 1.13ELror
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Table 7. Breed averages for pigs' humoral immune response to SRBC




R* SE R* SE R* SE
Secondary
SRBC titers 5.06 ' +1.94 bI4.00 +2.24 4.50 a'b +1.09
Secondary
PA titers 10.65 a +1.26 9.72 +1.27 9.71 +1.09
Average Daily .518 '3 +.11 .436 +.08 .33 c + .06
a,h,c Means in rryws with no ccnimil superscripts differ (P<0.01).
*Mean of agglutination titers in log 2 units.
Table 8. Breed averages for
from trial 2
pigs' humoral immune response to PmA
-*
X SEBreed
Hampsnire 9.22 b'c + .88
Yorkshire 9.78 a,b + .82
Duroc 8.78 (2 + 1.29
Landrace 10.41 a + .67




Hampshire X a,b,c9.57 + 1.14
Euroc
a'b'c Means in column with no common superscript
differ (P <.01)
Means of agglutination titers in log2 units
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Table 9. Coefficients of correlation between immune respenses
and average daily gain from trial 1.
Prob.
SRBC > R Fmk
Prob.
> R
PmA 0 .22 .007 1.0
X .06 .523 1.0
Y .31 .009 1.0
H .07 .771 1.0
ADG C .23 .005 .17 .001
X .25 .007 -.08 .398
Y .02 .845 .30 .012
H .18 .476 -.09 .727
0 - Overall Coefficients of ColLelations
X - Crossbred ChPfficients of Correlations
Y - Yorkshire Coefficients of CoLlelations
H - Hampshire Ccxfficients of CoLLelations
33
Figure 1: Statistical mcdel used in analyzing the experimental data.
yij = + + eij
where
= the agglutination titer of the pig,
= the overall constant,
th bi = fixed effect of the j breed and
eij = randan residual 
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